Real Time Screeners Intraday Screeners now on Real Time Data (Updated every 5 mins)
Stock Listing : A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z 

Income Statement of Jagsonpal Pharmaceuticals (JAGSNPHARM)

Summary    Balance Sheet    Cash Flow    Income    Qtrly Income    Risk    Profitability    Qtrly Profit    Solvency    

Income Statement of Jagsonpal Pharmaceuticals

Year 31_Mar_2019 31_Mar_2018 01_Apr_2017 31_Mar_2017 31_Mar_2016 31_Mar_2015 31_Mar_2014
Cost Of Revenue 72.85 61.29 59.91 58.95 60.53 69.45 68.51
Total Revenue/Income 166.83 126.53 144.06 143.87 143.49 138.15 143.85
Gross Profit 93.98 65.24 84.15 84.92 82.96 68.70 75.34
Total Operating Expense 158.51 137.96 140.10 139.75 134.18 132.03 135.99
Other Operating Expense 35.75 32.35 35.76 35.76 30.84 26.45 4.16
Operating Income/Profit 8.32 -11.43 3.97 4.12 9.31 6.12 7.86
Interest Expense 0.746 0.657 -2.47 2.50 -5.11 -4.13 -5.01
Net Income From Continuing Operation 7.22 -11.55 11.86 11.86 3.25 1.17 2.12
Depreciation Expense 1.02 1.06 1.99 1.99 3.09 2.71 2.83
Total Other Income Expense Net 0.683 -0.224 10.43 10.43 -5.23 -4.45 -5.33
Net Income 7.22 -11.55 11.86 11.86 3.25 1.17 2.12
Net Income Applicable to Common Share 7.22 -11.55 11.86 11.86 3.25 1.17 2.12
Income/Profit Before Tax 9.00 -11.63 14.40 14.40 4.08 1.67 2.53
Income Tax Expense 1.79 -0.076 2.53 2.53 0.821 0.501 0.411
EBIT 10.76 -9.91 3.97 18.89 9.31 6.12 7.86
EBITDA 10.76 -9.91 18.86 18.89 12.28 8.51 10.37
EPS (Earning Per Share) 2.75 -4.41 4.53 4.53 1.24 0.447 0.809
Total Dividend -0.655 -0.262 -0.262 -0.262 -0.262 -0.262 -1.31


Compund Annual Growth Rate (CAGR) of Jagsonpal Pharmaceuticals

Period 1 Year 3 Year 5 Year
Net Income From Continuing Operation 162.51 % -15.25 % 43.90 %
Net Income Applicable to Common Share 162.51 % -15.25 % 43.90 %
Net Income 162.51 % -15.25 % 43.90 %
Operating Income/Profit 172.79 % 26.40 % 6.33 %
Total Revenue/Income 31.85 % 5.06 % 3.84 %
Total Operating Expense 14.90 % 4.29 % 3.72 %
Other Operating Expense 10.51 % -0.0093 % 6.21 %
Income Tax Expense 2455.26 % -10.89 % 29.00 %
Total Other Income Expense Net 404.91 % -59.69 % 0.00
Interest Expense 13.55 % -33.18 % 0.00
Income/Profit Before Tax 177.39 % -14.50 % 40.06 %
EBIT 208.58 % -17.11 % 11.95 %
Total Dividend 150.00 % 35.72 % 20.11 %

About Financial Data , All results are consolidated, Values are in Crores, Sourced from external Vendors


( Intraday Analysis is on Real Time Data (Updated every 5 Mins). All Other analysis is based on End of Trade day's Value. Expected time of update is between 5 to 5.30 PM exchange time Zone)


All Rights Reserved By Mintnovate Market Research Pvt Ltd.